Could a smartphone app spot early signs of Alzheimer's?

NCT ID NCT07174869

Completed Knowledge-focused Sponsor: Indivi AG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times

Summary

This observational study tests a mobile app that uses a dynamic difficulty adjustment system to personalize cognitive activities for people with mild cognitive impairment or mild Alzheimer's disease, as well as healthy older adults. The goal is to see if the app can reach a stable difficulty level and whether that level differs between the two groups. Fifty-five participants will use the app for six weeks, and researchers will evaluate its ability to distinguish between those with and without cognitive decline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple app-based tool for early detection or monitoring of cognitive decline.
What could go wrong: This is a small pilot study (55 people) focused on usability and feasibility, not on treatment or diagnosis. The app may not reliably distinguish between groups in larger, more diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MILD ALZHEIMER DISEASE MILD COGNITIVE IMPAIRMENT (MCI)

Contacts and locations

Locations

Boston University School of Medicine

Boston, Massachusetts, 02118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.